Zobrazeno 1 - 10
of 18
pro vyhledávání: '"S M Mostofa Kamal"'
Autor:
Luca Freschi, Alena Skrahina, Maria Nakhoul, Nazir Ismail, Avika Dixit, Roger Vargas, Matthias I Gröschel, Sabira Tahseen, S M Masud Alam, S M Mostofa Kamal, Ramon P Basilio, Dodge R Lim, Maha R Farhat
Publikováno v:
BMJ Global Health, Vol 9, Iss 3 (2024)
Background Global tuberculosis (TB) drug resistance (DR) surveillance focuses on rifampicin. We examined the potential of public and surveillance Mycobacterium tuberculosis (Mtb) whole-genome sequencing (WGS) data, to generate expanded country-level
Externí odkaz:
https://doaj.org/article/18f8a98070f74b2fbac7400b045a066f
Autor:
Anna S Dean, Matteo Zignol, Andrea Maurizio Cabibbe, Dennis Falzon, Philippe Glaziou, Daniela Maria Cirillo, Claudio U Köser, Lice Y Gonzalez-Angulo, Olga Tosas-Auget, Nazir Ismail, Sabira Tahseen, Maria Cecilia G Ama, Alena Skrahina, Natavan Alikhanova, S M Mostofa Kamal, Katherine Floyd
Publikováno v:
PLoS Medicine, Vol 17, Iss 1, p e1003008 (2020)
BackgroundThe surveillance of drug resistance among tuberculosis (TB) patients is central to combatting the global TB epidemic and preventing the spread of antimicrobial resistance. Isoniazid and rifampicin are two of the most powerful first-line ant
Externí odkaz:
https://doaj.org/article/cc9e579bfe65452a8ee7d4ab7dcd6878
Autor:
Sarder Tanzir Hossain, Petros Isaakidis, Karuna D Sagili, Shayla Islam, Md Akramul Islam, Hemant Deepak Shewade, S M Mostofa Kamal, Ashaque Husain
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129155 (2015)
To determine, in areas supported by BRAC, Bangladesh i) the pre-diagnosis and pre-treatment attrition among presumptive and confirmed Multi-Drug Resistant Tuberculosis (MDR-TB) patients and ii) factors associated with attrition.This was a retrospecti
Externí odkaz:
https://doaj.org/article/9ac07ca3bc9b4e57a0259b3df99a3e68
Autor:
Tafsina Haque Aurin, Saurab Kishore Munshi, S M Mostofa Kamal, Md Mostafizur Rahman, Md Shamim Hossain, Thaythayhla Marma, Farjana Rahman, Rashed Noor
Publikováno v:
PLoS ONE, Vol 9, Iss 6, p e99810 (2014)
The principal obstacles in the treatment of tuberculosis (TB) are delayed and inaccurate diagnosis which often leads to the onset of the drug resistant TB cases. To avail the appropriate treatment of the patients and to hinder the transmission of dru
Externí odkaz:
https://doaj.org/article/84631249efb24d61981cf0723faf7b9e
Publikováno v:
Case Reports in Infectious Diseases, Vol 2019 (2019)
Chromobacterium violaceum is a Gram-negative bacterium, found in tropical and subtropical regions. C. violaceum infection rarely occurs, but once occurs, it is associated with significant mortality due to severe systemic infection. Since the first hu
Externí odkaz:
https://doaj.org/article/97cdf3a239f343eaa3a3735d4abdacac
Publikováno v:
International Journal of Mycobacteriology, Vol 1, Iss 4, Pp 190-195 (2012)
The present study was an attempt to establish a suitable method for the effective diagnosis of extra-pulmonary tuberculosis in Bangladesh. In this regard, detection of Mycobacterium tuberculosis from 390 different extra-pulmonary specimens was perfor
Externí odkaz:
https://doaj.org/article/3f0c0c2d40b84817bb0fd9e16ee5342c
Autor:
S. M. Mostofa Kamal, Shamim Hossain, Shirin Tarafder, Fatima Tuj Johora, Shaheda Anwar, S. M. Shahriar Rizvi
Publikováno v:
Journal of Tuberculosis Research. :228-237
Host factors, environmental factors, genetic diversity and distinct phylogeographic distribution of Mycobacterium tuberculosis (MTB) contribute to regional differences in drug resistance. Bangladesh remains among the top 20 high Multi drug resistant
Autor:
Delwar Hossain, Susanna Brighenti, Birgitta Agerberth, S. M. Mostofa Kamal, Inin Taznin, Md. Ahsanul Haq, Rubhana Raqib, Akhirunnesa Mily, Protim Sarker
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-15 (2020)
BMC Infectious Diseases
BMC Infectious Diseases
Background Diabetes mellitus type 2 (DM) may impede immune responses in tuberculosis (TB) and thus contribute to enhanced disease severity. In this study, we aimed to evaluate DM-mediated alterations in clinical, radiological and immunological outcom
Autor:
S. M. Mostofa Kamal, S. M. Shahriar Rizvi, Shaheda Anwar, Shirin Tarafder, Fatima Tuj Johora, Humayun Sattar, João Perdigão
Publikováno v:
Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 86
Bangladesh is among the high burden countries for tuberculosis (TB) and multidrug resistant TB (MDR-TB). As the genetic diversity and distinct phylogeographic distribution of Mycobacterium tuberculosis are responsible for regional differences in drug
Autor:
Akhirunnesa Mily, Protim Sarker, Inin Taznin, Delwar Hossain, Md. Ahsanul Haq, S. M. Mostofa Kamal, Agerberth, Birgitta, Brighenti, Susanna, Rubhana Raqib
Additional file 1 Table S1. Baseline clinical signs and symptoms of the study patients. Table S2. Hematological features in the TB and TB-DM patients and healthy controls. Table S3. Pulmonary pathology in TB-DM compared to TB patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00abf1864714874dc3f9b91821ea8e69